392 related articles for article (PubMed ID: 16690997)
1. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D
J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Paraskevas GP; Kapaki E; Nikolaou C; Zoga M; Rombos A; Tsoutsou A; Vassilopoulos D D
J Neurol Sci; 2006 Nov; 249(2):110-4. PubMed ID: 16843497
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
White LR; Gårseth M; Aasly J; Sonnewald U
J Neurosci Res; 2004 Oct; 78(2):297-301. PubMed ID: 15378514
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
de la Monte SM; Volicer L; Hauser SL; Wands JR
Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
8. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
[TBL] [Abstract][Full Text] [Related]
9. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P
Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
[TBL] [Abstract][Full Text] [Related]
10. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
[TBL] [Abstract][Full Text] [Related]
11. Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.
Sáez-Valero J; Costell M; Sjögren M; Andreasen N; Blennow K; Luque JM
J Neurosci Res; 2003 Apr; 72(1):132-6. PubMed ID: 12645087
[TBL] [Abstract][Full Text] [Related]
12. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
Wada-Isoe K; Wakutani Y; Urakami K; Nakashima K
Acta Neurol Scand; 2004 Aug; 110(2):124-7. PubMed ID: 15242421
[TBL] [Abstract][Full Text] [Related]
13. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders.
Cacabelos R; Barquero M; García P; Alvarez XA; Varela de Seijas E
Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):455-8. PubMed ID: 1784142
[TBL] [Abstract][Full Text] [Related]
15. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer-related neuronal protein A68: specificity and distribution.
Wolozin B; Davies P
Ann Neurol; 1987 Oct; 22(4):521-6. PubMed ID: 3435070
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
Ryberg H; Söderling AS; Davidsson P; Blennow K; Caidahl K; Persson LI
Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
[TBL] [Abstract][Full Text] [Related]
18. What is 'early onset dementia'?
Miyoshi K
Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
Mihara M; Hattori N; Abe K; Sakoda S; Sawada T
Neuroreport; 2006 Mar; 17(4):413-6. PubMed ID: 16514368
[TBL] [Abstract][Full Text] [Related]
20. Circulating interleukin-10 and interleukin-12 in Parkinson's disease.
Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
Acta Neurol Scand; 2009 May; 119(5):332-7. PubMed ID: 18976327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
